Home » Topics » Regulatory » Patents

Patents
RSS

HMR continues to focus R&D resources in the area of Na+/H+ exchange inhibitors

April 14, 1999

Production method and structure of all-trans-retinol metabolite disclosed by WARF

April 14, 1999

Serotonergic agents for depression under study at BASF

April 14, 1999

Roche describes preparation and use of cell adhesion inhibitors for chronic inflammatory disorders

April 14, 1999

Peptidomimetic inhibitors of cellular Ras protein processing developed at Merck

April 14, 1999

Warner-Lambert prepares naphthyridinone kinase and cell proliferation inhibitors

April 13, 1999

Broad-spectrum antifungal agents in development at Merck

April 13, 1999

IP receptor antagonists from Roche with potential as analgesic/antiinflammatory agents

April 13, 1999

Novel Roche peptides useful for bone disorders

April 13, 1999

ADIR prepares structurally novel compounds as venotropic agents

April 12, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...